Bausch + Lomb (BLCO)
(Delayed Data from NYSE)
$13.50 USD
-0.13 (-0.95%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $13.50 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Bausch + Lomb Corporation's dividend yield currently sits at 0%, which is in-line with the Medical Services industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
BLCO 13.50 -0.13(-0.95%)
Will BLCO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BLCO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BLCO
Bausch + Lomb (BLCO) Reports Q2 Earnings: What Key Metrics Have to Say
Bausch + Lomb (BLCO) Q2 Earnings and Revenues Surpass Estimates
BLCO: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Sell Stocks for July 30th
New Strong Sell Stocks for July 24th
Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
Other News for BLCO
Bausch & Lomb (BLCO) Receives Updated Price Target from Morgan Stanley | BLCO Stock News
Bausch + Lomb (BLCO) Price Target Increased to $16 by H.C. Wainwright
Bausch + Lomb price target raised by $1 at H.C. Wainwright, here's why
Wells Fargo Raises Price Target for Bausch & Lomb (BLCO) to $15.00 | BLCO Stock News
Market Today: Meta and Microsoft Lead AI Surge, AbbVie Eyes Acquisition